{'fraction_non_alphanumeric': 0.018852459016393444, 'fraction_numerical': 0.01639344262295082, 'mean_word_length': 4.705607476635514, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Emerging Drugs for the Treatment of Cancer Pain: A Review of Patent Literature in 2014.

BACKGROUND
Pain in oncology patients may be related to underlying disease process, as well as a side effect of chemotherapy and radiation. More than half of all patients with a diagnosis of cancer experience pain, which is often poorly controlled. As such, the treatment of pain in oncology patients demonstrates a significant need to develop new treatment options.


OBJECTIVE
This review summarizes 35 patents on the treatment of pain among cancer patients.


METHOD
A thorough literature review of all patents filed in 2014 was conducted using PubMed and http://ep.espacenet.com/ as sources identify new treatment options for cancer pain.


RESULTS
Our literature search returned 35 patents filed in 2014 related to the treatment of pain in cancer patients.


CONCLUSION
In 2014, a number of patents were filed for the treatment of pain among oncology patients. The great variety of chemical compounds presented indicates that there is a great variety in current research for cancer-related pain. The development of novel treatment options will hopefully lead to more effective therapies in the treatment of cancer-related pain.